Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biolife Sciences Inc BLFE

BioLife Sciences Inc. is a commercialization accelerator, licensor, and disruptive technologies for the healthcare, beauty, and food and beverage industry sectors. The Company’s core business develops, licenses and distributes antimicrobial products and disruptive technology. Its solutions include Antimicrobial Copper Air Filters, Copper-Infused Textiles and Copper Infused Fabric Pots. The... see more

GREY:BLFE - Post Discussion

Biolife Sciences Inc > BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent
View:
Post by AveragePenny on Feb 03, 2023 11:30am

BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent

Henderson NV - (NewMediaWire) - February 02, 2023 - BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into a non-binding letter of intent (“LOI”) dated February 01, 2023 with Canadian Company–Work In Motion pursuant to which the parties will complete an exclusive licensing agreement for the development and commercialization of custom designed copper infused bamboo gardening gloves.

 

Transaction

The final structure of the Transaction will be determined by the parties following corporate and securities law advice. The Transaction is an arm’s length transaction and pursuant to the terms of the LOI the parties intend to sign a definitive agreement (the “Definitive Agreement”) in respect of the Transaction; BioLife Sciences is intended to assume sole responsibility for the development and commercialization of private label copper infused bamboo gardening gloves.

Completion of the Transaction is subject to a number of conditions, including but not limited to the following key conditions:

 

  • execution of the Definitive Agreement.
  • completion of mutually satisfactory due diligence; and
  • successful sourcing of required equipment and design specifications.
Be the first to comment on this post